Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N P Restifo

Showing results (21-30 of 97) with videos related to

Pageof 10
Sort By:
Methods (San Diego, Calif.)|June 1, 1997
Identification of a Kb-restricted CTL epitope of beta-galactosidase: potential use in development of immunization protocols for "self" antigensW W Overwijk, D R Surman, K Tsung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1995
Synthetic oligonucleotide expressed by a recombinant vaccinia virus elicits therapeutic CTLK R Irvine, B J McCabe, S A Rosenberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1996
Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastasesK R Irvine, J B Rao, S A Rosenberg, et al.
Cancer Research|January 19, 1999
Human melanoma cells do not express Fas (Apo-1/CD95) ligandD B Chappell, T Z Zaks, S A Rosenberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 27, 1999
Fas-mediated suicide of tumor-reactive T cells following activation by specific tumor: selective rescue by caspase inhibitionT Z Zaks, D B Chappell, S A Rosenberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2000
Cutting edge: CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigenD R Surman, M E Dudley, W W Overwijk, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1995
Anti-tumor activity of cytotoxic T lymphocytes elicited with recombinant and synthetic forms of a model tumor-associated antigenM Wang, P W Chen, V Bronte, et al.
World Journal of Urology|June 15, 2000
Antitumor efficacy of tumor-antigen-encoding recombinant poxvirus immunization in Dunning rat prostate cancer: implications for clinical genetic vaccine developmentL G Charles, Y C Xie, N P Restifo, et al.
Cancer Research|January 26, 2000
Enhancement of tumor-specific immune response with plasmid DNA replicon vectorsW W Leitner, H Ying, D A Driver, et al.
Journal of the National Cancer Institute|March 5, 1997
Route of immunization and the therapeutic impact of recombinant anticancer vaccinesK R Irvine, R S Chamberlain, E P Shulman, et al.
Pageof 10

Showing results (21-30 of 97) with videos related to

Sort By:
Pageof 10
Methods (San Diego, Calif.)|June 1, 1997
Identification of a Kb-restricted CTL epitope of beta-galactosidase: potential use in development of immunization protocols for "self" antigensW W Overwijk, D R Surman, K Tsung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1995
Synthetic oligonucleotide expressed by a recombinant vaccinia virus elicits therapeutic CTLK R Irvine, B J McCabe, S A Rosenberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1996
Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastasesK R Irvine, J B Rao, S A Rosenberg, et al.
Cancer Research|January 19, 1999
Human melanoma cells do not express Fas (Apo-1/CD95) ligandD B Chappell, T Z Zaks, S A Rosenberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 27, 1999
Fas-mediated suicide of tumor-reactive T cells following activation by specific tumor: selective rescue by caspase inhibitionT Z Zaks, D B Chappell, S A Rosenberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2000
Cutting edge: CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigenD R Surman, M E Dudley, W W Overwijk, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1995
Anti-tumor activity of cytotoxic T lymphocytes elicited with recombinant and synthetic forms of a model tumor-associated antigenM Wang, P W Chen, V Bronte, et al.
World Journal of Urology|June 15, 2000
Antitumor efficacy of tumor-antigen-encoding recombinant poxvirus immunization in Dunning rat prostate cancer: implications for clinical genetic vaccine developmentL G Charles, Y C Xie, N P Restifo, et al.
Cancer Research|January 26, 2000
Enhancement of tumor-specific immune response with plasmid DNA replicon vectorsW W Leitner, H Ying, D A Driver, et al.
Journal of the National Cancer Institute|March 5, 1997
Route of immunization and the therapeutic impact of recombinant anticancer vaccinesK R Irvine, R S Chamberlain, E P Shulman, et al.
Pageof 10